These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area? Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955 [TBL] [Abstract][Full Text] [Related]
3. Normal Patterns and Pitfalls of FDG Uptake in the Head and Neck. Gray BR; Koontz NA Semin Ultrasound CT MR; 2019 Oct; 40(5):367-375. PubMed ID: 31635764 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria. Min M; Lin P; Lee M; Ho Shon I; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):393-401. PubMed ID: 26782837 [TBL] [Abstract][Full Text] [Related]
5. CT, MRI, and Kim HY; Hwang JY; Kim HJ; Kim YK; Cha J; Park GM; Kim ST Acta Radiol; 2017 Oct; 58(10):1222-1230. PubMed ID: 28068826 [TBL] [Abstract][Full Text] [Related]
6. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma. Kitajima K; Suenaga Y; Sugimura K Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982 [TBL] [Abstract][Full Text] [Related]
7. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma. Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443 [TBL] [Abstract][Full Text] [Related]
8. Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer. Kumar R; Mukherjee A; Mittal BR PET Clin; 2016 Jan; 11(1):13-20. PubMed ID: 26590440 [TBL] [Abstract][Full Text] [Related]
9. Clinical impact of Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225 [TBL] [Abstract][Full Text] [Related]
10. Advances in Functional Imaging in the Assessment of Head and Neck Cancer. Wan DQ Oral Maxillofac Surg Clin North Am; 2019 Nov; 31(4):627-635. PubMed ID: 31473063 [TBL] [Abstract][Full Text] [Related]
11. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938 [TBL] [Abstract][Full Text] [Related]
12. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer. Platzek I PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244 [TBL] [Abstract][Full Text] [Related]
13. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma. Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372 [TBL] [Abstract][Full Text] [Related]
14. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging. Højgaard L; Berthelsen AK; Loft A PET Clin; 2014 Apr; 9(2):141-5. PubMed ID: 25030278 [TBL] [Abstract][Full Text] [Related]
15. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI. Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645 [TBL] [Abstract][Full Text] [Related]
16. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
17. Fine needle aspiration diagnosis of benign oncocytic lesions of the head and neck associated with false positive Hussain M; Ghani H; Ali Y; Clement C; Nawgiri R Diagn Cytopathol; 2024 Jul; 52(7):387-392. PubMed ID: 38712593 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors. Al-Bulushi NK; Abouzied ME Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992 [TBL] [Abstract][Full Text] [Related]
19. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318 [TBL] [Abstract][Full Text] [Related]
20. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]